iSpeak Blog
ISPE marked a major milestone at the 2025 ISPE Annual Meeting & Expo, celebrating 45 years of progress while surpassing 25,000 members worldwide and reaching more than 100,000...
ISPE
Shape the Future of Pharma
<p>ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.</p>
Related Articles
InTouch
ISPE’s FOYA program recognizes state-of-the-art projects using innovative technologies to improve the quality of products, reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery for the benefit of humanity.
InTouch
ISPE has announced the establishment of the ISPE Radiopharmaceuticals Community of Practice (CoP). This initiative intends to respond to the rapid growth and unique complexities of the radiopharmaceuticals field, which is critically advancing precision medicine for conditions such as cancer.
InTouch
Advanced therapy medicinal products (ATMPs) are redefining what’s possible in medicine, but their promise comes with a challenge the industry can no longer afford to postpone: how to scale manufacturing in a way that is cost-effective, resilient, and patient-ready.
InTouch
In each issue of Pharmaceutical Engineering®, we introduce a member of the ISPE staff who provides ISPE members with key information and services. Meet Gabbi Jimenez, Graphic Designer, Marketing & Communications team.
iSpeak Blog
AI is no longer a future concept for life sciences—it is a present-day force reshaping how medicines are developed, manufactured, regulated, and delivered to patients. Yet as AI adoption accelerates, a critical truth has become clear: technology alone is not enough. Sustainable, compliant, and scalable AI transformation depends on people, culture, governance, and organizational readiness.